Spyre Therapeutics, Inc. (SYRE)
104.00
+1.09
(+1.06%)
USD |
NASDAQ |
Nov 13, 16:00
103.00
-1.00
(-0.96%)
Pre-Market: 08:23
Spyre Therapeutics Price : 104.00 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 102.33 | 104.50 | 100.49 | 104.00 | 746235.0 |
| Nov 12, 2026 | 104.80 | 105.28 | 101.40 | 102.91 | 985835.0 |
| Nov 11, 2026 | 104.21 | 107.87 | 103.72 | 106.82 | 894998.0 |
| Nov 10, 2026 | 107.07 | 109.15 | 103.19 | 104.48 | 1.004M |
| Nov 09, 2026 | 105.59 | 110.64 | 104.41 | 109.00 | 1.394M |
| Nov 06, 2026 | 98.35 | 104.30 | 97.29 | 103.86 | 1.635M |
| Nov 05, 2026 | 98.38 | 98.74 | 93.83 | 96.59 | 1.160M |
| Nov 04, 2026 | 99.00 | 100.00 | 92.77 | 99.04 | 1.495M |
| Nov 03, 2026 | 97.04 | 100.00 | 96.51 | 99.27 | 904899.0 |
| Nov 02, 2026 | 97.11 | 98.13 | 93.82 | 95.51 | 752066.0 |
| Oct 30, 2026 | 96.78 | 98.96 | 94.68 | 96.56 | 661127.0 |
| Oct 29, 2026 | 99.71 | 100.42 | 97.95 | 98.96 | 567637.0 |
| Oct 28, 2026 | 98.39 | 100.14 | 97.55 | 99.75 | 724549.0 |
| Oct 27, 2026 | 93.00 | 99.24 | 92.37 | 99.04 | 944931.0 |
| Oct 26, 2026 | 91.54 | 94.19 | 90.35 | 92.91 | 637181.0 |
| Oct 23, 2026 | 90.70 | 91.90 | 88.69 | 90.33 | 503013.0 |
| Oct 22, 2026 | 92.95 | 94.56 | 91.27 | 92.33 | 802950.0 |
| Oct 21, 2026 | 92.78 | 95.17 | 92.32 | 92.95 | 1.153M |
| Oct 20, 2026 | 85.12 | 93.22 | 85.08 | 91.40 | 1.709M |
| Oct 19, 2026 | 82.29 | 86.05 | 80.94 | 84.72 | 1.272M |
| Oct 16, 2026 | 80.21 | 80.52 | 78.12 | 79.90 | 1.273M |
| Oct 15, 2026 | 76.87 | 80.88 | 76.87 | 80.10 | 1.148M |
| Oct 14, 2026 | 80.13 | 82.45 | 77.95 | 78.63 | 1.625M |
| Oct 13, 2026 | 85.12 | 85.32 | 80.45 | 80.45 | 1.441M |
| Oct 12, 2026 | 86.30 | 86.62 | 84.21 | 85.90 | 873909.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 295.03 |
| Incyte Corp. | 120.97 |
| SELLAS Life Sciences Group, Inc. | 7.86 |
| Relay Therapeutics, Inc. | 18.09 |
| ACADIA Pharmaceuticals, Inc. | 18.75 |
Price Related Metrics
| PEG Ratio | -0.8116 |
| Price to Book Value | 10.34 |
| Earnings Yield | -2.96% |
| Market Cap | 9.355B |
| PEGY Ratio | -0.8116 |